Preclinical (translational) research is one of the first steps in your journey from idea to product. It is of crucial importance to design the appropriate preclinical study protocol which will lead you to the desired results.
When designing a new preclinical study, our efforts are targeted on optimizing research outcomes while reducing animal numbers, regulatory burden and additional costs.
Our expertise are planning and conducting preclinical studies that will fit your needs and budget constraints. Our team will assist you with integrating preclinical and clinical questions, choosing the most appropriate animal model and analyse the study outcomes in order to complete the animal testing through the most efficient pathway and attain a regulatory clearance/approval.
CTNT’s team can assist you with the following activities of the preclinical phase: